Are people really getting excited over an annoyingly common genetic mutation and talking about it being commercially worth something haha?? Yep, sums things up haha. Classic. One mans trash is another’s treasure I guess.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025